Merck

The move is expected to cut costs for many patients, but it faces litigation from drugmakers and heavy criticism from Republican lawmakers. read more >

The drugmaker is seeking to halt the program, which was laid out in the Inflation Reduction Act and is expected to save taxpayers billions of dollars in the coming years. read more >

The drugmakers said it led to a statistically significant improvement in survival. read more >

A decision could come in weeks. read more >

President Donald Trump on Tuesday ripped into the four business leaders who resigned from his White House jobs panel — the latest sign that corporate America's romance with Trump is faltering — after his equivocal response to violence by white supremacists in Charlottesville, Virginia. read more >